Shareholding disclosure

Mark N Lampert

Declared position

24.61%

Threshold

Crossed upwards

Timeline

Published

14.11.2014

Transaction

31.10.2014

Voting rights breakdown

Voting rights acquired24.61%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBEBA00037

Beneficial owner

Mark N Lampert

Declared address

Mark N Lampert, Chicago, Illinois 60611

BVF Partners L.P. and BVF Inc. are considered as indirect holders of the securities.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Mark N Lampert

Addex Therapeutics Ltd14.11.2014TBEBA00037

Disclosure summary

Mark N Lampert disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 14.11.2014, at 24.61% of voting rights. Notice category: Group of shareholders.

Disclosed position

24.61%

Voting rights acquired

Voting rights acquired24.61%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Mark N Lampert disclosed a holding in Addex Therapeutics Ltd, published on 14.11.2014.

Publication date14.11.2014

Transaction date31.10.2014

Issuing companyAddex Therapeutics Ltd

Beneficial ownerMark N Lampert

Declared addressMark N Lampert, Chicago, Illinois 60611

CategoryGroup of shareholders

Voting rights acquired24.61%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBEBA00037

Conditions

BVF Partners L.P. and BVF Inc. are considered as indirect holders of the securities.

Source: SIX Exchange Regulation · Publication date: 14.11.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open